Ocular Therapeutix (OCUL) Enters $40M Controlled Equity Offering Sales Agreement
Tweet Send to a Friend
Ocular Therapeutix (Nasdaq: OCUL) disclosed the following in a U.S. SEC filing on Wednesday:Item 1.01 Entry into a Material Definitive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
